RT-100
Glp-3 rt
$56.00
Retatrutide aims to address various metabolic disorders through its unique pharmacological profile. Ongoing studies are evaluating its efficacy and safety, highlighting Retatrutides promise in advancing treatment options. Researchers anticipate that successful outcomes wil
Size
In stock · 10 mg / vial · ships in 1–2 business days
- Purity
- ≥ 99% (HPLC)
- Quantity
- 10 mg / vial
- Form
- Lyophilized powder
- Molecular weight
- —
- Stock status
- In stock
- Source
- freedom diagnostics
- Lot / batch
- PNWP260230154
Certificate of Analysis
Third-party HPLC and MS results for PNWP260230154. View COA
Storage information
Store lyophilized material at -20 °C, protected from light and moisture. Once reconstituted for laboratory work, keep at 2–8 °C and avoid repeated freeze-thaw cycles.
Shipping
Insulated packaging with tracked domestic and international delivery. Import eligibility is the purchaser's responsibility.
Research Use Only
Intended solely for laboratory and in-vitro research by qualified professionals. Not approved for human consumption, veterinary use, or the diagnosis, treatment, cure, or prevention of any disease. Not a drug, supplement, food, or cosmetic.
Product description
Lyophilized Retatrutide peptide, supplied in 10mg and 20mg vial sizes, HPLC-verified to greater than 99% purity. Retatrutide is studied in the scientific literature as a triple hormone receptor agonist, activating the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors simultaneously, distinguishing it from single- or dual-receptor agonist peptides.
In metabolic research models, retatrutide has been investigated for its effects on energy expenditure, glucose homeostasis, and lipid metabolism through its combined action on these three receptor pathways. Researchers studying incretin biology and metabolic hormone signaling use this class of compounds to better understand the interplay between these receptor systems in laboratory models.
Each vial is supplied in lyophilized (freeze-dried) powder form to maintain peptide stability during shipping and storage. After reconstitution with an appropriate diluent, solutions should be stored refrigerated and used according to your laboratory's standard handling protocols. See our Reconstitution Guide for detailed instructions.
This product is supplied strictly for laboratory research use only (RUO). It is not a drug, dietary supplement, or cosmetic, and is not intended for human or animal consumption, diagnosis, treatment, cure, or prevention of any disease. Purchasers must be qualified researchers, laboratories, or institutions acquiring this product for legitimate scientific research purposes only, in full accordance with our Terms of Service and RUO Disclaimer.
| Lab reference | 2606230154 |
| Chromatographic purity | 99.86% |
| Quantity found | 11.54 mg |
| Mass spectral match | Confirmed |
| Analysis date | 23 June 2026 |
| Report issued | 25 June 2026 |
| CAS |
Glp-3 rt reference information
Vial and presentation
Each Glp-3 rt vial is supplied as lyophilized powder at 10mg / vial, sealed and labelled with catalogue code RT-100. Vials are inspected before release and shipped in insulated packaging.
Purity and testing
Identity and purity are confirmed by third-party HPLC and mass spectrometry, with the result stated as ≥ 99% (HPLC). Lot-specific analysis is available on request.
Storage
Store lyophilized material at -20 °C, protected from light and moisture. Once reconstituted for laboratory work, keep at 2–8 °C and avoid repeated freeze-thaw cycles.
Reconstitution
Reconstitution for laboratory work is performed with bacteriostatic water or another suitable diluent, added slowly against the vial wall and swirled rather than shaken. Record the volume used so concentrations remain traceable. Supplied for research use only; not for human or veterinary use.
Other reference materials
